NCT03675191View on ClinicalTrials.gov

Orlistat/Phentermine Versus Placebo/Phentermine

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

July 12, 2019

Study Completion Date

August 12, 2019

Conditions
ObesityOverweight
Interventions
DRUG

Orlistat 120Mg Cap

Drug,Orlistat 120Mg Cap, three times a day, within 1hour after meal

DRUG

Phentermine Pill

Drug,Phentermine Pill 37.5mg, both in two arms, one time a day, within 1hour after meal

Trial Locations (1)

17046

Yongin Severance Hospital, Yongin-si

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT03675191 - Orlistat/Phentermine Versus Placebo/Phentermine | Biotech Hunter | Biotech Hunter